Perspective Therapeutics, Inc. (CATX)

NYSEAMERICAN: CATX · Real-Time Price · USD

5.55

+0.13 (2.40%)

At close: Feb 25, 2026, 4:00 PM EST

5.60

+0.05 (0.90%)

After-hours: Feb 25, 2026, 4:55 PM EST

Revenue by Segment

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021	Jun '20 Jun 30, 2020	Jun '19 Jun 30, 2019	Jun '18 Jun 30, 2018	Jun '17 Jun 30, 2017	Jun '16 Jun 30, 2016
Drug Operations	1.45M	1.43M			-	-	-
Drug Operations Growth	1.39%	-			-	-	-
Isotope-Based Medical Devices	-	-			10.05M	9.68M	7.31M
Isotope-Based Medical Devices Growth	-	-			3.85%	32.35%	23.48%
Total	1.45M	1.43M			10.05M	9.68M	7.31M
Total Growth	1.39%	-			3.85%	32.35%	23.48%

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021	Jun '20 Jun 30, 2020	Jun '19 Jun 30, 2019	Jun '18 Jun 30, 2018	Jun '17 Jun 30, 2017	Jun '16 Jun 30, 2016
United States	1.45M	1.43M			10.05M	9.68M	7.27M
United States Growth	1.39%	-			3.84%	33.15%	23.52%
Non - United States	-	-			5.03K	3.87K	46.81K
Non - United States Growth	-	-			29.80%	-91.73%	17.96%
Total	1.45M	1.43M			10.05M	9.68M	7.31M
Total Growth	1.39%	-			3.85%	32.35%	23.48%

Source: S&P Global Market Intelligence.